SEP 03, 2019 1:47 PM PDT

Urine test detects cancer: watch out for blue pee!

New research from MIT engineers and Imperial and published in Nature Nanotechnology could change the way to detect cancer. The study highlights the development of a non-invasive nanotechnology capable of detecting cancer through a urine test. So far the technology has only been proven in mice for colon cancer, but the researchers say the technology holds potential for the future of cancer detection.

The research was led by Imperial's Professor Molly Stevens and MIT professor and Howard Hughes Medical Institute investigator Sangeeta Bhatia. Together, the researchers developed a system where nanosensors are injected into mice, which are then broken up by protease enzymes that are released by cancer tumors. The broken-up nanosensors are then small enough to come out in the mouse’s urine. The researchers then are able to conduct a urine test that detects the presence of nanosensors by changing the urine to blue.

New research could change the way we detect cancer tumors. Photo: Pixabay

In simpler terms, if the urine turns blue, that means there is a tumor present. The researchers conducted the experiment on 28 mice, 14 of which were healthy and 14 of which had colon tumors. The test showed splendid results, demonstrating a change in blue color for those mice with tumors within only a half hour after the nanosensors were injected. Furthermore, there were no side-effects seen in the mice from the injections during the four-week follow-up.

The importance of this detection tool lies principally in its rapid answer and inexpensive cost. As Professor Stevens, of Imperial's Departments of Materials and Bioengineering, commented "By taking advantage of a chemical reaction that produces a color change, this test can be administered without the need for expensive and hard-to-use lab instruments. The simple readout could potentially be captured by a smartphone picture and transmitted to remote caregivers to connect patients to treatment."

The researchers say that although there is more work to be done before their technology can be tested in humans, they have hope that it will be helpful not only for cancer detection, but also other diseases.

"Proteases play functional roles in a number of diseases such as cancer, infectious diseases, inflammation, and thrombosis," said co-first author Ava Soleimany, of Harvard and MIT. "By designing versions of our sensors that can be cut by different proteases, we could apply this colour-based test to detect a diversity of conditions."

Sources: Science Daily, Nature Nanotechnology

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
SEP 21, 2020
Cancer
Black women have delayed and longer breast cancer treatment
SEP 21, 2020
Black women have delayed and longer breast cancer treatment
A study led by UNC Lineberger Comprehensive Cancer Center researchers has quantified the healthcare inequities in cancer ...
OCT 04, 2020
Cancer
Mutations form in specific genomic patterns based on external and internal factors
OCT 04, 2020
Mutations form in specific genomic patterns based on external and internal factors
New research published in Nature Genetics provides insight on the formation of mutations in the genome. Researchers from ...
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
NOV 17, 2020
Clinical & Molecular DX
Tumor Stiffness Linked to Its Aggressiveness
NOV 17, 2020
Tumor Stiffness Linked to Its Aggressiveness
  As tumors grow, tiny areas at their cores are found to become stiff prior to metastasis, or the spread of cancer ...
Loading Comments...